Abstract:BACKGROUND:Mutations in the SPAST gene are the most frequent cause of hereditary spastic paraplegia (HSP). We aim to extend the mutation spectrum of spastic paraplegia 4 (SPG4) and carried out experiment in vitro to explore the influence of the SPAST gene mutation on the function of corresponding protein.METHODS:Whole-exome sequencing (WES) combined with multiplex ligation-dependent probe amplification (MLPA) were performed in a cohort of 150 patients clinically diagnosed with HSP. We focus on screening for mutations in SPAST gene and carrying out functional experiments to assess the effects of the novel variants.RESULTS:A total of 34 different mutations in the SPAST gene were identified, of which 10 were novel, including 1 missense (c.1479T > A), 1 nonsense (c.766G > T), 3 splicing (c.1413 + 1_1413+4delGTAA, c.1729-1G > A and c.1536+2T > G) and 5 frameshift mutations (c.1094delC, c.885dupA, c.517_518delAG, c.280delG and c.908dupC). For 7 novel non-splicing mutations, functional study showed that accumulated M1 spastin colcocalized with microtubules which was different from a uniformly diffused M87 spastin. While an impairment in severing activity was observed in both mutant M1 and mutant M87, except for c.280delG. All 3 novel splicing variants w ere predicted to affect splicing by using bioinformatic programs. However, only c.1536+2T > G had no influence on splice site in vitro, which conflicts with the in-silico analysis.CONCLUSION:We genetically diagnosed 40 SPG4 patients. All the novel non-splicing mutations except for c.280delG were certified to exert an effect on the microtubule-severing and all the novel splicing mutations other than c.1536+2T > G would cause abnormal splicing of the spastin.

Expanding SPG18 clinical spectrum: autosomal dominant mutation causes complicated hereditary spastic paraplegia in a large family

Novel Mutations in Endoplasmic Reticulum Lipid Raft-associated Protein 2 Gene Cause Pure Hereditary Spastic Paraplegia Type 18

[The Clinical Characteristics of a Pedigree with Incompletely Penetrated Autosomal Dominant Hereditary Spastic Paraplegia and Its Exclusion Analysis of Genetic Loci].

Receptor Expression-Enhancing Protein 1 Gene (SPG31) Mutations Are Rare in Chinese Han Patients with Hereditary Spastic Paraplegia.

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

Exon 8-17 Deletions of Spast in A Chinese Family with Hereditary Spastic Paraplegia: A Case Report and Literature Review

Advances in the Molecular Genetics of Autosomal Dominant Hereditary Spastic Paraplegia

Expansion of the Phenotypic Spectrum of SPG6 Caused by Mutation in NIPA1.

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

Characteristics of Clinical and Spastin Gene Mutation in a Family with Hereditary Spastic Paraplegia

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

A Novel Candidate Locus on Chromosome 11P14.1-P11.2 for Autosomal Dominant Hereditary Spastic Paraplegia

Genetic Analysis of SPG4 and SPG3A Genes in a Cohort of Chinese Patients with Hereditary Spastic Paraplegia.

Chinese Families with Autosomal Recessive Hereditary Spastic Paraplegia Caused by Mutations in SPG11

Hereditary spastic paraparesis type 46 (SPG46): new GBA2 variants in a large Italian case series and review of the literature

Early Diagnosis of AP5Z1/SPG48 Spastic Paraplegia: Case Report and Review of the Literature

PLP1 Gene Mutations Cause Spastic Paraplegia Type 2 in Three Families.

Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia

AAA ATPases and Hereditary Spastic Paraplegia

Autosomal Dominant Hereditary Spastic Paraplegia Caused by Mutation of UBAP1.

A novel missense mutation in SPAST causes hereditary spastic paraplegia in male members of a family: A case report